Rather than simply blocking these enzymes, copper peptides promote the synthesis of tissue inhibitors of metalloproteinases (TIMPs), creating a balanced environment where old, damaged collagen is removed while new, healthy collagen is produced
A series of treatments is generally needed to achieve the desired results
Theoretical interaction concerns include other compounds affecting c-Met signaling, cancer treatments (especially c-Met inhibitors used in oncology), and any medication affecting hepatic metabolism
Copper overload: Unlikely at typical doses but avoid excessive use
These processes are closely interrelated, amplifying each other and contributing to long-term neuronal damage and neurodegeneration
Standard dosing typically starts at 250 mcg daily, administered subcutaneously